Together with our previous results, our findings suggest that perinatal reinstatement of TCF4 holds the greatest potential to treat behavioral symptoms of PTHS, with likely vastly diminishing therapeutic benefits upon juvenile reinstatement. This evidence concerns the gene TCF4 and Pitt-Hopkins syndrome.